478 filings
Page 5 of 24
8-K
KALA
Kala Bio Inc.
3 Mar 23
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
8:05am
PRE 14A
KALA
Kala Bio Inc.
Preliminary proxy
1 Mar 23
4:33pm
SC 13D/A
KALA
Kala Bio Inc.
14 Feb 23
Kala Pharmaceuticals / Longitude Capital Partners II ownership change
12:00am
SC 13G
Baker Bros. Advisors LP
14 Feb 23
Kala Pharmaceuticals / BAKER BROS. ADVISORS ownership change
12:00am
8-K
KALA
Kala Bio Inc.
19 Jan 23
Entry into a Material Definitive Agreement
4:14pm
424B5
KALA
Kala Bio Inc.
19 Jan 23
Prospectus supplement for primary offering
4:05pm
SC 13G
KALA
Kala Bio Inc.
17 Jan 23
Kala Pharmaceuticals / INTEGRATED CORE STRATEGIES ownership change
4:38pm
8-K
KALA
Kala Bio Inc.
10 Jan 23
Other Events
7:05am
4
Darius Kharabi
6 Jan 23
Kala Pharmaceuticals / Darius Kharabi ownership change
8:00pm
4
Trachtenberg Eric
6 Jan 23
Kala Pharmaceuticals / Eric Trachtenberg ownership change
8:00pm
4
Reumuth Mary
6 Jan 23
Kala Pharmaceuticals / Mary Reumuth ownership change
8:00pm
4
KALA
Kala Bio Inc.
6 Jan 23
Kala Pharmaceuticals / Romulus K Brazzell ownership change
8:00pm
4
Bazemore Todd
6 Jan 23
Kala Pharmaceuticals / Todd Bazemore ownership change
8:00pm
4
KALA
Kala Bio Inc.
6 Jan 23
Kala Pharmaceuticals / Mark T Iwicki ownership change
8:00pm
S-8
KALA
Kala Bio Inc.
4 Jan 23
Registration of securities for employees
4:13pm
8-K
KALA
Kala Bio Inc.
27 Dec 22
Entry into a Material Definitive Agreement
4:13pm
8-K
KALA
Kala Bio Inc.
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
KALA
Kala Bio Inc.
28 Nov 22
Entry into a Material Definitive Agreement
4:52pm
10-Q
2022 Q3
KALA
Kala Bio Inc.
Quarterly report
8 Nov 22
4:01pm
8-K
KALA
Kala Bio Inc.
8 Nov 22
Kala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:05am